Logo image of BRZE

BRAZE INC-A (BRZE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BRZE - US10576N1028 - Common Stock

35.4 USD
-0.43 (-1.2%)
Last: 12/26/2025, 8:00:02 PM
35.4 USD
0 (0%)
After Hours: 12/26/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, BRZE scores 4 out of 10 in our fundamental rating. BRZE was compared to 278 industry peers in the Software industry. The financial health of BRZE is average, but there are quite some concerns on its profitability. BRZE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BRZE had positive earnings in the past year.
In the past year BRZE had a positive cash flow from operations.
In the past 5 years BRZE always reported negative net income.
In multiple years BRZE reported negative operating cash flow during the last 5 years.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

BRZE has a worse Return On Assets (-11.22%) than 64.03% of its industry peers.
BRZE has a Return On Equity (-19.41%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

BRZE has a Gross Margin (68.13%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRZE has grown nicely.
The Profit Margin and Operating Margin are not available for BRZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRZE has been increased compared to 1 year ago.
BRZE has more shares outstanding than it did 5 years ago.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

BRZE has an Altman-Z score of 4.95. This indicates that BRZE is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.95, BRZE is doing good in the industry, outperforming 70.14% of the companies in the same industry.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.95
ROIC/WACCN/A
WACC10.99%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.36 indicates that BRZE should not have too much problems paying its short term obligations.
BRZE has a Current ratio of 1.36. This is comparable to the rest of the industry: BRZE outperforms 42.09% of its industry peers.
A Quick Ratio of 1.36 indicates that BRZE should not have too much problems paying its short term obligations.
BRZE has a Quick ratio of 1.36. This is comparable to the rest of the industry: BRZE outperforms 42.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

7

3. Growth

3.1 Past

BRZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1900.00%, which is quite impressive.
BRZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.95%.
The Revenue has been growing by 43.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%

3.2 Future

BRZE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.56% yearly.
BRZE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.76% yearly.
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y69.64%
EPS Next 5Y56.56%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.25%
Revenue Next 5Y17.76%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 88.50, BRZE can be considered very expensive at the moment.
BRZE's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BRZE to the average of the S&P500 Index (26.57), we can say BRZE is valued expensively.
The Price/Forward Earnings ratio is 67.62, which means the current valuation is very expensive for BRZE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRZE is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, BRZE is valued quite expensively.
Industry RankSector Rank
PE 88.5
Fwd PE 67.62
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

BRZE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 66.32
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BRZE's earnings are expected to grow with 69.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y70.55%
EPS Next 3Y69.64%

0

5. Dividend

5.1 Amount

No dividends for BRZE!.
Industry RankSector Rank
Dividend Yield 0%

BRAZE INC-A

NASDAQ:BRZE (12/26/2025, 8:00:02 PM)

After market: 35.4 0 (0%)

35.4

-0.43 (-1.2%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09 2025-12-09/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners77.58%
Inst Owner Change6.91%
Ins Owners9.5%
Ins Owner Change5.69%
Market Cap3.94B
Revenue(TTM)693.41M
Net Income(TTM)-116.88M
Analysts84.62
Price Target47.63 (34.55%)
Short Float %6.17%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)192.95%
Min EPS beat(2)-5.12%
Max EPS beat(2)391.01%
EPS beat(4)3
Avg EPS beat(4)140.47%
Min EPS beat(4)-5.12%
Max EPS beat(4)391.01%
EPS beat(8)7
Avg EPS beat(8)191.16%
EPS beat(12)11
Avg EPS beat(12)143.38%
EPS beat(16)15
Avg EPS beat(16)112.23%
Revenue beat(2)2
Avg Revenue beat(2)2.72%
Min Revenue beat(2)1.64%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.64%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.47%
Revenue beat(12)12
Avg Revenue beat(12)1.76%
Revenue beat(16)16
Avg Revenue beat(16)2.28%
PT rev (1m)0%
PT rev (3m)-0.63%
EPS NQ rev (1m)8.18%
EPS NQ rev (3m)16.88%
EPS NY rev (1m)0%
EPS NY rev (3m)139.87%
Revenue NQ rev (1m)2.63%
Revenue NQ rev (3m)2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 88.5
Fwd PE 67.62
P/S 5.68
P/FCF 66.32
P/OCF 56.97
P/B 6.54
P/tB 14.56
EV/EBITDA N/A
EPS(TTM)0.4
EY1.13%
EPS(NY)0.52
Fwd EY1.48%
FCF(TTM)0.53
FCFY1.51%
OCF(TTM)0.62
OCFY1.76%
SpS6.23
BVpS5.41
TBVpS2.43
PEG (NY)0.66
PEG (5Y)N/A
Graham Number6.98
Profitability
Industry RankSector Rank
ROA -11.22%
ROE -19.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.13%
FCFM 8.56%
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 60.58%
Cap/Sales 1.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 4.95
F-Score4
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y69.64%
EPS Next 5Y56.56%
Revenue 1Y (TTM)22.95%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%25.51%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.25%
Revenue Next 5Y17.76%
EBIT growth 1Y4.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year771.27%
EBIT Next 3Y181.62%
EBIT Next 5Y120.97%
FCF growth 1Y1317.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2175.29%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / BRZE FAQ

Can you provide the ChartMill fundamental rating for BRAZE INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to BRZE.


What is the valuation status of BRAZE INC-A (BRZE) stock?

ChartMill assigns a valuation rating of 3 / 10 to BRAZE INC-A (BRZE). This can be considered as Overvalued.


How profitable is BRAZE INC-A (BRZE) stock?

BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for BRZE stock?

The Price/Earnings (PE) ratio for BRAZE INC-A (BRZE) is 88.5 and the Price/Book (PB) ratio is 6.54.


What is the earnings growth outlook for BRAZE INC-A?

The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 133.15% in the next year.